Evidence map›Paper›PMID 28919823›Full record

ReviewInternational journal of women's health2017

Updated approaches for management of uterine fibroids.

Aymara Mas, Marta Tarazona, Joana Dasí Carrasco, Gloria Estaca, Ignacio Cristóbal, Javier Monleón

Registry-linked trialAbstract readReview
In one paragraph

Review in International journal of women's health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05151393 (Correlation Between Serum Vitamin D3 Level and Incidence of Uterine Leiomyoma in Egyptian Women), which is not on this map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05151393 unknown statusnot on this mapstarted 2021, after this paper: background citation

Correlation Between Serum Vitamin D3 Level and Incidence of Uterine Leiomyoma in Egyptian Women

TypeobservationalSponsorAin Shams UniversityRan2021 to 2022Enrolled80ConditionsVitamin D Deficiency, LeiomyomaArmsMeasuring vitamin D3 level
3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Leveraging artificial intelligence for evidence-based recommendations in uterine fibroid therapy: Addressing the unmet need in German healthcare-A clinical trial.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. The Role of Nanomedicine in Benign Gynecologic Disorders.Molecules (Basel, Switzerland) · 2024
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Observational
  19. Surgical Treatment of "Large Uterine Masses" in Pregnancy: A Single-Center Experience.International journal of environmental research and public health · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aymara MasReproductive Medicine Research Group, Institute of Health Research La Fe, University and Polytechnic Hospital La Fe, Valencia, Spain.
Marta TarazonaGynecology Department, University and Polytechnic Hospital La Fe, Valencia, Spain.
Joana Dasí CarrascoGynecology Department, University and Polytechnic Hospital La Fe, Valencia, Spain.
Gloria EstacaObstetrics and Gynecology Department, La Zarzuela Hospital, Madrid, Spain.
Ignacio CristóbalObstetrics and Gynecology Department, La Zarzuela Hospital, Madrid, Spain.
Javier MonleónGynecology Department, University and Polytechnic Hospital La Fe, Valencia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Uterine anatomy and uterine fibroids (UFs) characteristics have been classically considered as almost a unique issue in gynecology and reproductive medicine. Nowadays, the management of UF pathology is undergoing an important evolution, with the patient's quality of life being the most important aspect to consider. Accordingly, surgical techniques and aggressive treatments are reserved for only those cases with heavy symptomatology, while the clinical diagnostic based on size and number of UFs remains in a second plane in these situations. Moreover, the development of several noninvasive surgical techniques, especially the appearance of ulipristal acetate as a medical etiological treatment, has substantially changed the clinical indications. As a consequence, after almost 2 decades without relevant updates, it has been necessary to update the protocols for the management of UFs in the Spanish Society of Gynecology and Obstetrics twice. Accordingly, we believe that it is necessary to translate our experience to protocolize the medical care for patients with UFs, incorporating these new therapeutic options, and selecting the best treatment for them. We highlight the importance of achieving the patient's goals and decisions by improving the clinical diagnosis for these type of pathologies, allowing enhanced personalized treatments, as well as the reduction of potential risks and unnecessary surgeries.

Indexed as

selective progesterone receptor modulatorsPRMUFsulipristal acetateUPAuterine fibroids

Identifiers

PMID28919823
PMCPMC5592915

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.